HUMAN MACHINE INTERACTION

  • pharma industry needs precise fda guidelines for ai ml and rpa validation experts

    Pharma Industry Needs Precise FDA Guidelines for AI, ML, and RPA Validation : Experts

    ​Experts at the second edition of Next-Gen LabCon discussed the capabilities of artificial intelligence (AI), machine learning (ML), and robotic process automation (RPA) in enhancing research and development (R&D) processes. The panel experts underscored the transformative potential of AI, ML, and RPA in pharmaceutical R&D while highlighting the critical need for human expertise and robust regulatory frameworks.

    • Exclusive

Join the community of 2M+ industry professionals

Subscribe to our Daily Newsletter

By continuing you agree to our Privacy Policy & Terms & Conditions

Download ETHealthworld App for Realtime updates

Seamless reading experience. Save your favourite.

Scan to download App

Download ETHealthworld App for Realtime updates of content you follow

  • Seamless reading experience
  • Save your favourite articles
Advertisement
Advertisement